Wednesday, August 07, 2019 12:44:26 PM
Company not very forthcoming on guidance, other indications etc. Not unusual for such a small company.
I would have liked a more in depth answer on the Grifols/Xemblify question.
I was hopeful the legal fees would be minimized for rest of year. Company indicated otherwise.
I’m wondering if a reasonable settlement (if possible) would be best way to go.
I have zero knowledge of the complexities of the case etc.
Plan on holding this long term as the story is solid. My largest position (MJCO, BMRA)
Encouraged by bounce, so far, directly off the 10 week moving average.
Not unreasonable for this to consolidate for some time after huge % move.
Of course I’d prefer a quick move to $4.50 :$
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM